Status: current, Primitive. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4023124019 | Brexucabtagene autoleucel | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4023125018 | Brexucabtagene autoleucel (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brexucabtagene autoleucel | Is a | Genetically modified T-cell | true | Inferred relationship | Some | ||
| Brexucabtagene autoleucel | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brexucabtagene autoleucel-containing product | Has active ingredient | True | Brexucabtagene autoleucel | Inferred relationship | Some | 1 |
| Brexucabtagene autoleucel only product | Has active ingredient | True | Brexucabtagene autoleucel | Inferred relationship | Some | 1 |
| Brexucabtagene autoleucel-containing product in parenteral dose form | Has active ingredient | True | Brexucabtagene autoleucel | Inferred relationship | Some | 1 |
| Brexucabtagene autoleucel only product in parenteral dose form | Has active ingredient | True | Brexucabtagene autoleucel | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR